Nicola Simola holds an M.S. degree in pharmaceutical chemistry and a Ph.D. degree in pharmacology of drug dependence. Dr. Simola currently performs his research in the Department of Biomedical Sciences of the University of Cagliari, Cagliari, Italy, where he works as an Assistant Professor of pharmacology. His research involves the study and development of new therapeutic agents for the treatment of Parkinson’s disease, focusing on adenosine receptor antagonists, the development of new preclinical models of early-stage Parkinson’s disease, and the study of the interactions between caffeine and other recreational psychostimulants.
Biography Updated on 9 January 2013